The pandemic was a watershed moment for Color’s leadership team, who have been steadily pivoting the company into a broader mission of expanding access to health care. Editor's note: As part of the ...

Echoing much of the existing data and research on the subject, SF-based Color released data today showing that based on its own testing program, most individuals who test positive for COVID-19 display ...

Color recently raised $100 million in equity, tripling its valuation since it closed a funding round in January. It’s now valued at $4.6 billion. Kindred Ventures and funds advised by T. Rowe Price ...

SAN FRANCISCO (KGO) -- Thousands of people across the Bay Area have been on the hunt for a COVID testing site while others who were lucky to find open slots are having to wait hours to get tested.

As Stanford students seek to comply with the University’s COVID-19 testing requirements, many are reporting delays in receiving their Color test results, with some reporting turnaround times of up to ...

After gathering multiple emergency authorizations from the FDA last year for COVID-19 testing and self-sampling kits, Color has now raised $167 million in venture capital financing to help scale up ...

The University has implemented a new testing system with the company Color in order to accommodate the influx of returning sophomores and new freshmen on campus. While some students have found it to ...

Northwestern will resume COVID-19 testing with Color on Mar. 1 after winter storm-related test shipment delays prompted the University to pause testing with the company, according to a Friday email.

23andMe in June started trading after going public in a deal that valued the company at $3.5 billion. Despite 23andMe's success, the consumer genomics market has largely bottomed out, an analyst said.